COMMUNIQUÉ DE PRESSE publié le 01/02/2023 à 15:45, il y a 1 année 8 mois Jaguar Health & SynWorld Technologies Mutually Agree to Terminate License and Commercialization Agreement for Canalevia for Treatment of Diarrhea in Dogs in China Given Jaguar’s 2023 Focus on Human Drug Development
COMMUNIQUÉ DE PRESSE publié le 01/02/2023 à 14:30, il y a 1 année 8 mois Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling
COMMUNIQUÉ DE PRESSE publié le 30/01/2023 à 14:30, il y a 1 année 8 mois Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise
COMMUNIQUÉ DE PRESSE publié le 27/01/2023 à 22:15, il y a 1 année 9 mois Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
COMMUNIQUÉ DE PRESSE publié le 26/01/2023 à 14:30, il y a 1 année 9 mois Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe
COMMUNIQUÉ DE PRESSE publié le 25/01/2023 à 14:30, il y a 1 année 9 mois Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer
COMMUNIQUÉ DE PRESSE publié le 23/01/2023 à 14:30, il y a 1 année 9 mois Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences
COMMUNIQUÉ DE PRESSE publié le 20/01/2023 à 18:45, il y a 1 année 9 mois Jaguar Health Reports Voting Results from January 2023 Special Meeting of Stockholders
COMMUNIQUÉ DE PRESSE publié le 20/01/2023 à 14:30, il y a 1 année 9 mois Jaguar Health to Present at Lytham Partners Investor Select Conference on January 31st
COMMUNIQUÉ DE PRESSE publié le 12/01/2023 à 01:10, il y a 1 année 9 mois REMINDER: Jaguar Health to Hold Investor Webcast Thursday, January 12th at 10:30 AM EST to Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Jaguar’s Mental Health Entheogen Therapeutics Initiative (ETI) to Discover Novel Therapies Der
Publié le 29/10/2024 à 17:40, il y a 12 heures 52 minutes Mersen to acquire Bar-Lo carbon products to consolidate its material strategy in the United States
Publié le 29/10/2024 à 17:40, il y a 12 heures 52 minutes Mersen acquiert Bar-Lo Carbon Products pour consolider sa stratégie matériaux aux États-Unis
Publié le 30/10/2024 à 01:15, il y a 5 heures 17 minutes LQWD Grants Incentive Stock Options to Key Management
Publié le 29/10/2024 à 22:10, il y a 8 heures 22 minutes Electric Metals Announces DSU and Stock Option Grant
Publié le 29/10/2024 à 20:15, il y a 10 heures 17 minutes Tenth Avenue Petroleum Executes Definitive Agreement To Acquire Low Decline, Production In Southern Alberta
Publié le 30/10/2024 à 04:12, il y a 2 heures 19 minutes EQS-Adhoc: Dexus Finance Pty Limited: Dexus 2024 AGM Chair and CEO address
Publié le 30/10/2024 à 00:17, il y a 6 heures 14 minutes EQS-Adhoc: Dexus Finance Pty Limited: September 2024 quarter update
Publié le 29/10/2024 à 23:56, il y a 6 heures 35 minutes grenke publishes preliminary figures for the third quarter of 2024
Publié le 29/10/2024 à 23:23, il y a 7 heures 8 minutes EQS-Adhoc: grenke reduces Group earnings guidance
Publié le 29/10/2024 à 20:34, il y a 9 heures 57 minutes EQS-Adhoc: Daimler Truck Holding AG: Release
